Erasca Inc (ERAS)

03:20 AM

Erasca (ERAS) adds 13%; soars 310% YTD - MSN

03:20 AM

Mar 23, 2026

Assessing Erasca (ERAS) Valuation After ERAS-0015 Licensing Win And Data Anticipation - Yahoo Finance

Mar 23, 2026

Mar 22, 2026

Certain Stock Options of Erasca, Inc. are subject to a Lock-Up Agreement Ending on 23-MAR-2026. - marketscreener.com

Mar 22, 2026

Mar 21, 2026

TNGX stock hits record high on inking collaboration deal with ERAS - MSN

Mar 21, 2026

Mar 20, 2026

How Erasca’s Expanded ERAS-0015 License and Narrower 2025 Loss Will Impact Erasca (ERAS) Investors - simplywall.st

Mar 20, 2026

Mar 20, 2026

Erasca (ERAS) Adds 13%; Soars 310% YTD - Yahoo Finance

Mar 20, 2026

Mar 19, 2026

5 Stocks Dominating Today’s Market Action - Insider Monkey

Mar 19, 2026

Mar 19, 2026

Erasca (NASDAQ:ERAS) Shares Up 10.3% on Better-Than-Expected Earnings - MarketBeat

Mar 19, 2026

Mar 18, 2026

Guggenheim more than doubles Erasca (ERAS) PT following clinical progress and updated pipeline models - MSN

Mar 18, 2026

Mar 18, 2026

ERAS Surges as JP Morgan Raises Price Target | ERAS Stock News - GuruFocus

Mar 18, 2026

Mar 18, 2026

JPMorgan Chase & Co. Increases Erasca (NASDAQ:ERAS) Price Target to $25.00 - MarketBeat

Mar 18, 2026

Mar 17, 2026

Analysts Offer Insights on Healthcare Companies: BeOne Medicines (ONC), Argenx Se (ARGX) and Erasca (ERAS) - The Globe and Mail

Mar 17, 2026

Mar 17, 2026

Erasca Inc stock hits 52-week high at $14.63 - Investing.com Nigeria

Mar 17, 2026

Mar 17, 2026

Erasca, Inc. (NASDAQ:ERAS) Given Average Rating of "Moderate Buy" by Analysts - MarketBeat

Mar 17, 2026

Mar 16, 2026

Chipmakers Recap: Should I invest in Erasca Inc before earnings2026 Valuation Update & Weekly Sector Rotation Insights - baoquankhu1.vn

Mar 16, 2026

Mar 16, 2026

Erasca Form 144: Foundation Lists Proposed Common Sales | ERAS SEC FilingForm 144 - Stock Titan

Mar 16, 2026

Mar 16, 2026

Erasca (NASDAQ:ERAS) Stock Price Expected to Rise, Guggenheim Analyst Says - MarketBeat

Mar 16, 2026

Mar 15, 2026

Erasca’s Stock Faces Pressure as CMO Offloads Shares - StocksToTrade

Mar 15, 2026

Mar 15, 2026

uniQure, Syndax and Erasca Are Drawing Analyst Interest Ahead of Key Drug Catalysts - AOL.com

Mar 15, 2026

Mar 15, 2026

Erasca’s CMO Stock Sale Raises Eyebrows Amid Market Uncertainty - timothysykes.com

Mar 15, 2026

Mar 14, 2026

FTAI Aviation To Rally More Than 43%? Here Are 10 Top Analyst Forecasts For Friday - Sahm

Mar 14, 2026

Mar 14, 2026

Assessing Tango Therapeutics (TNGX) Valuation After Vopimetostat Progress And New Erasca Collaboration - simplywall.st

Mar 14, 2026

Mar 14, 2026

Erasca secures worldwide rights to RAS-targeting drug ERAS-0015 By Investing.com - Investing.com Nigeria

Mar 14, 2026

Mar 14, 2026

Erasca’s Chief Medical Officer Divests Shares Amid Strategic Uncertainties​ - StocksToTrade

Mar 14, 2026

Mar 14, 2026

Analysts Offer Insights on Healthcare Companies: Oric Pharmaceuticals (ORIC), MindWalk Holdings (HYFT) and Erasca (ERAS) - The Globe and Mail

Mar 14, 2026

Mar 13, 2026

Erasca (NASDAQ:ERAS) Price Target Raised to $18.00 at Piper Sandler - MarketBeat

Mar 13, 2026

Mar 13, 2026

Erasca stock price target raised to $20 by H.C. Wainwright on trial data - Investing.com Nigeria

Mar 13, 2026

Mar 13, 2026

Erasca (NASDAQ:ERAS) Stock Price Expected to Rise, Mizuho Analyst Says - MarketBeat

Mar 13, 2026

Mar 13, 2026

Erasca (NASDAQ:ERAS) Given New $20.00 Price Target at HC Wainwright - MarketBeat

Mar 13, 2026

Mar 13, 2026

Stifel reiterates Buy rating on Erasca stock, $20 target By Investing.com - Investing.com Canada

Mar 13, 2026

Mar 13, 2026

Stifel reiterates Buy rating on Erasca stock, $20 target - Investing.com

Mar 13, 2026

Mar 13, 2026

Decoding Erasca Inc (ERAS): A Strategic SWOT Insight - GuruFocus

Mar 13, 2026

Mar 12, 2026

Erasca, Inc. 2025 Annual Report: Erasing Cancer with Modality-Agnostic RAS/MAPK Pathway Therapeutics and Innovative Precision Oncology Strategies - Minichart

Mar 12, 2026

Mar 12, 2026

Erasca Reports Fourth Quarter and Full Year 2025 Business Updates and Financial Results - The Manila Times

Mar 12, 2026

Mar 12, 2026

Erasca 10-K: Net loss $124.55M; cash and securities $341.8M - TradingView

Mar 12, 2026

Mar 12, 2026

Erasca, Inc. Reports Earnings Results for the Full Year Ended December 31, 2025 - marketscreener.com

Mar 12, 2026

Mar 12, 2026

Erasca (NASDAQ: ERAS) narrows 2025 loss and funds runway into H2 2028 - Stock Titan

Mar 12, 2026

Mar 12, 2026

Cancer-drug maker Erasca raises $259M, says cash lasts to 2028 - Stock Titan

Mar 12, 2026

Mar 12, 2026

A Look At Erasca (ERAS) Valuation After Securing Global Rights To ERAS-0015 - simplywall.st

Mar 12, 2026

Mar 12, 2026

Erasca (ERAS) to Release Earnings on Thursday - MarketBeat

Mar 12, 2026

Mar 11, 2026

Stifel raises Erasca stock price target to $20 on China expansion - Investing.com India

Mar 11, 2026

Mar 10, 2026

Stifel raises Erasca stock price target to $20 on China expansion By Investing.com - Investing.com South Africa

Mar 10, 2026